[Prevention of hemorrhage occurring in patients with leukemia].
Sakakura
Miho
M
Wada
Hideo
H
D000925:Anticoagulants / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D016670:Gabexate / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000150:complications* / Q000628:therapy; D017713:Platelet Transfusion / Q000009:adverse effects; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000209:etiology / Q000628:therapy; D014212:Tretinoin / Q000627:therapeutic use; D014813:Vitamin K Deficiency / Q000209:etiology
D000925:Anticoagulants; D015842:Serine Proteinase Inhibitors; D016670:Gabexate; D014212:Tretinoin; D006493:Heparin